LBL-015

· Nanjing Leads Biolabs Co.,Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LBL-015, covering 2024-10-28 to 2024-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Clinical Trial of LBL-015 for Injection [Phase 1, Phase 2]